ESOT Congress 2025: Scientists create functional human islets in 3D printing breakthrough for type 1 diabetes treatment
LONDON, June 29, 2025 /PRNewswire/ -- A team of international scientists has made a major leap forward in diabetes research by successfully 3D printing functional human islets using a novel bioink. Presented today at the ESOT Congress 2025, the new technology could pave the way for more effective and less invasive treatment for people living with type 1 diabetes.
The breakthrough involved printing human islets – the insulin-producing clusters of cells in the pancreas – using a customised bioink made from alginate and decellularised human pancreatic tissue. This approach produced durable, high-density islet structures that remained alive and functional for up to three weeks, maintaining strong insulin responses to glucose and showing real potential for future clinical use.
Traditional islet transplants are typically infused into the liver, a process that can result in significant loss of cells and limited long-term success. In contrast, the 3D-printed islets were designed to be implanted just under the skin, a simple procedure requiring only local anaesthesia and a small incision. This minimally invasive approach could offer a safer and more comfortable option for patients.
"Our goal was to recreate the natural environment of the pancreas so that transplanted cells would survive and function better," explained lead author Dr. Quentin Perrier. "We used a special bioink that mimics the support structure of the pancreas, giving islets the oxygen and nutrients they need to thrive."
The bioprinted islets stayed alive and healthy, with over 90% cell survival. They responded better to glucose than standard islet preparations, releasing more insulin when it was needed. By day 21, the islets showed a stronger ability to sense and react to blood sugar levels – an important sign that they could work well after being implanted. The constructs maintained their structure without clumping or breaking down, overcoming a common hurdle in earlier approaches.
Additionally, the 3D-printed structures featured a porous architecture that enhanced the flow of oxygen and nutrients to the embedded islets. This design helped maintain cell health and promoted vascularisation, both of which are critical for long-term survival and function after transplantation.
"This is one of the first studies to use real human islets instead of animal cells in bioprinting, and the results are incredibly promising," noted Dr. Perrier. "We're getting closer to creating an off-the-shelf treatment for diabetes that could one day eliminate the need for insulin injections."
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Korea Herald
10 hours ago
- Korea Herald
ESOT Congress 2025: Scientists create functional human islets in 3D printing breakthrough for type 1 diabetes treatment
LONDON, June 29, 2025 /PRNewswire/ -- A team of international scientists has made a major leap forward in diabetes research by successfully 3D printing functional human islets using a novel bioink. Presented today at the ESOT Congress 2025, the new technology could pave the way for more effective and less invasive treatment for people living with type 1 diabetes. The breakthrough involved printing human islets – the insulin-producing clusters of cells in the pancreas – using a customised bioink made from alginate and decellularised human pancreatic tissue. This approach produced durable, high-density islet structures that remained alive and functional for up to three weeks, maintaining strong insulin responses to glucose and showing real potential for future clinical use. Traditional islet transplants are typically infused into the liver, a process that can result in significant loss of cells and limited long-term success. In contrast, the 3D-printed islets were designed to be implanted just under the skin, a simple procedure requiring only local anaesthesia and a small incision. This minimally invasive approach could offer a safer and more comfortable option for patients. "Our goal was to recreate the natural environment of the pancreas so that transplanted cells would survive and function better," explained lead author Dr. Quentin Perrier. "We used a special bioink that mimics the support structure of the pancreas, giving islets the oxygen and nutrients they need to thrive." The bioprinted islets stayed alive and healthy, with over 90% cell survival. They responded better to glucose than standard islet preparations, releasing more insulin when it was needed. By day 21, the islets showed a stronger ability to sense and react to blood sugar levels – an important sign that they could work well after being implanted. The constructs maintained their structure without clumping or breaking down, overcoming a common hurdle in earlier approaches. Additionally, the 3D-printed structures featured a porous architecture that enhanced the flow of oxygen and nutrients to the embedded islets. This design helped maintain cell health and promoted vascularisation, both of which are critical for long-term survival and function after transplantation. "This is one of the first studies to use real human islets instead of animal cells in bioprinting, and the results are incredibly promising," noted Dr. Perrier. "We're getting closer to creating an off-the-shelf treatment for diabetes that could one day eliminate the need for insulin injections."
Korea Herald
2 days ago
- Korea Herald
Ph fintech GCash unlocks insurance for 14 million Filipinos
MANILA, Philippines, June 27, 2025 /PRNewswire/ -- Insurance has traditionally been perceived as a luxury for many Filipinos, often sidelined due to daily financial priorities. GCash, the country's leading finance super app, is changing this through its digital insurance platform, GInsure. Launched in 2021, GInsure offers flexible, straightforward, and affordable coverage and is conveniently available on a platform trusted by millions. As of the first quarter of 2025, GInsure has unlocked insurance for over 14.6 million users, issuing more than 51.4 million policies. "We are humbled to be able to come to the aid of users who are looking for a more affordable and accessible way to protect themselves and their loved ones," said Winsley Bangit, GCash VP and Head of New Businesses. Focusing on affordability, GCash enables more Filipinos to build financial resilience. Users can select from over 48 insurance products in the app's Marketplace, covering Health, Life, Travel, and more, underwritten by GCash's partners. Protection can also be enhanced when transacting online. For instance, "Express Send Scam Insurance" provides personal cyber protection for just Php30 for 30 days. More recently, GInsure introduced "Buy Load Plus Health Insurance", offering free health and accident insurance to customers purchasing mobile load credits via the GCash app. Eligible users can receive up to Php 30,000 in free accident and health insurance benefits, including hospital income coverage of Php 500 per day for up to 5 days if unable to work at no additional cost. For GCash, micro-insurance is a practical way to extend financial protection to those traditionally uninsured or under-insured, addressing communities with the greatest need but limited access to conventional products. This initiative helps make financial protection a realistic part of everyday life for millions of Filipinos. For more details, visit
Korea Herald
2 days ago
- Korea Herald
Dongying enhances wetland conservation to safeguard migratory birds
DONGYING, China, June 26, 2025 /PRNewswire/ -- A news report from A critical stopover on two major migratory bird flyways, Dongying city in East China's Shandong province has emerged as a leader in habitat protection and ecological restoration within the Yellow River Delta. In late April, the Yellow River Delta National Nature Reserve celebrated the hatching of its first artificially incubated crested ibis chick of the year — nearly a month earlier than in 2024. The milestone was particularly welcome, because it's said to signal the growing adaptation of the species to the local environment. "The earlier hatching provides the chick with more favorable conditions for growth and shows the crested ibis' successful acclimatization to the Yellow River estuary," said Wang Andong, head of the reserve's research center. Once critically endangered, the crested ibis was reintroduced to the reserve in 2022 with 20 individuals translocated from Hanzhong city in China's Northwest Shaanxi province. By the 2024 breeding season, the population had already produced 20 new chicks through a mix of artificial incubation and natural breeding. These achievements stem from years of targeted conservation efforts. Since 2016, Dongying has collaborated with research institutions to implement customized restoration techniques. These include controlling invasive species like Spartina alterniflora, a coastal cordgrass native to the US, reviving native vegetation and supplying over 510 million cubic meters of ecological water in the past three years. According to Zhao Yajie, deputy director of the reserve, an integrated monitoring system — combining satellite, aerial and ground-based tracking — enables real-time observation of bird activity. In 2025, the reserve recorded a historic high of 233 oriental storks' nests, yielding 536 chicks. Staff also conduct satellite tracking and behavioral studies on juvenile birds to ensure their survival. Fieldwork is viewed as remaining essential to Dongying's success. Zhao recalled wading through icy mud to rescue a fallen black-headed gull chick — a testament to the team's dedication. Today, the reserve shelters 374 bird species — nearly double the original count. "With sustained ecological efforts, more species will continue to make Dongying their home," Zhao noted.
